ANI Pharmaceuticals/ US00182C1036 /
| 26/07/2024 21:59:56 | Chg. +1.30 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 63.23USD | +2.10% | 6,791 Turnover: 424,291.75 |
-Bid Size: - | -Ask Size: - | 1.33 bill.USD | - | 73.55 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.86 USD | - |
| EPS Diluted: | 0.85 USD | - |
| Revenues per Share: | 23.11 USD | 27.76% |
| Book Value per Share: | 20.54 USD | 14.55% |
| Cash Flow per Share: | 5.65 USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 486.82 USD | - |
| Net Income: | 17.15 USD | - |
| Operating Cash Flow: | 118.96 USD | - |
| Cash and Cash Equivalents: | 221.12 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 73.55 | 64.12 |
| P/S Ratio: | 2.74 | 2.39 |
| P/BV ratio: | 3.08 | 2.68 |
| P/CF Ratio: | 11.20 | 9.77 |
| PEG: | - | - |
| Earnings Yield: | 1.36% | 1.56% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 1.33 bill. USD | 1.16 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 20.96 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | - |
| Net Profit Margin: | - |
| Return on Equity: | - |
| Return on Assets: | - |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | - |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
